{"altmetric_id":3081143,"counts":{"readers":{"mendeley":22,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["seeking_alpha"],"posts_count":1},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["Peertechz"],"posts_count":1}},"citation":{"abstract":"Biologic agents have revolutionized the management of psoriasis but at a higher cost compared with \"traditional\" agents. Cost must be considered when evaluating management options for psoriasis.","abstract_source":"pubmed","altmetric_jid":"56c1ef532a83ee09648b4a4e","authors":["Judy Cheng","Steven R Feldman"],"doi":"10.7573\/dic.212266","endpage":"10","first_seen_on":"2015-01-20T12:50:14+00:00","funders":["niehs"],"isbns":[],"issns":["1745-1981","17404398"],"journal":"Drugs in Context","last_mentioned_on":1459444594,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25598832","http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4295913\/"],"pmid":"25598832","pubdate":"2014-01-01T00:00:00+00:00","publisher":"JUST Medical Media Limited","startpage":"1","title":"The cost of biologics for psoriasis is increasing.","type":"article","volume":"3","mendeley_url":"http:\/\/www.mendeley.com\/research\/cost-biologics-psoriasis-increasing"},"altmetric_score":{"score":9.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.5},"context_for_score":{"all":{"total_number_of_other_articles":7471181,"mean":6.4836306053357,"rank":761333,"this_scored_higher_than_pct":89,"this_scored_higher_than":6699420,"rank_type":"exact","sample_size":7471181,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":233971,"mean":7.920352934137,"rank":30555,"this_scored_higher_than_pct":86,"this_scored_higher_than":202877,"rank_type":"exact","sample_size":233971,"percentile":86},"this_journal":{"total_number_of_other_articles":9,"mean":4.71875,"rank":2,"this_scored_higher_than_pct":77,"this_scored_higher_than":7,"rank_type":"exact","sample_size":9,"percentile":77},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":2,"Student  > Doctoral Student":3,"Researcher":5,"Student  > Ph. D. Student":2,"Student  > Postgraduate":3,"Student  > Master":1,"Other":1,"Student  > Bachelor":3,"Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":9,"Agricultural and Biological Sciences":3,"Nursing and Health Professions":1,"Business, Management and Accounting":2,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":5,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"IN":1},"mendeley":{"US":1,"IN":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Peertechz\/status\/557512326526402562","license":"datasift","citation_ids":[3081143],"posted_on":"2015-01-20T12:17:51+00:00","author":{"name":"Peertechz Pub PvtLtd","url":"https:\/\/www.peertechz.com","image":"https:\/\/pbs.twimg.com\/profile_images\/808685119959535616\/cV4vMlOy_normal.jpg","description":"Peertechz Publications Pvt. Ltd. is an international open access, peer-reviewed podium which aims to provide scientists, researchers, academicians...","id_on_source":"Peertechz","tweeter_id":"2472672241","geo":{"lt":17.38405,"ln":78.45636,"country":"IN"},"followers":314},"tweet_id":"557512326526402562"}],"news":[{"title":"Cellceutix: Still Flying Under The Radar--An Innovative Biotech With Tremendous Upside Potential","url":"http:\/\/ct.moreover.com\/?a=26011260817&p=1pl&v=1&x=Sx2cmywnxmVnwdunlD5t6A","license":"public","citation_ids":[4552403,6419460,2582978,562940,4683926,4944703,6009330,4687382,6200374,6419465,150025,4749009,3081143,1690629,4938657,1690629,6419467,6419469,4774833,2031950,6361178,2494133,14185710],"posted_on":"2016-03-31T17:16:34+00:00","summary":"Discussion Outline Introduction: Focusing on Facts, not Fiction Brilacidin: Lead Candidate in New Class of Antibiotics Kevetrin: Novel p53-Activating Oncology Drug Prurisol: An Oral Anti-Psoriasis Compound Conclusion: Liking the Odds, Liking the\u2026","author":{"name":"Seeking Alpha","url":"http:\/\/seekingalpha.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/665\/normal\/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}]}}